Asthma Therapeutics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Asthma is a chronic lung disease in which inflammation causes the bronchi to swell and narrow, resulting in breathing difficulties that can range from mild to life-threatening in considerable number of cases. The symptoms of asthma include, chest tightness, cough ,shortness of breath and wheezing. Asthma is caused by a number of environmental factors, including allergen exposure and air pollution. Asthma has been proven to have no cure, although it can be managed with early and effective asthma therapy. Anti-inflammatory drugs, corticosteroids, long-acting beta-agonists (LABA), and leukotriene modifiers are among the therapies used to treat asthma.

MARKET SCOPE

The "Global Asthma Therapeutics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the asthma therapeutics market with detailed market segmentation by product type, drug class, route of administration. The report provides key statistics on the market status of the leading asthma therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on product type the market is segmented as, dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer.
  
•   Based on drug class the market is segmented as, anti-inflammatory drugs, bronchodilators and combination therapy.
  
•   Based on route of administration the market is segmented as, oral, inhaled, intravenous and subcutaneous.
  

MARKET DYNAMICS

Drivers:

•   Increasing incidences of asthma and other respiratory disorders.
  
•   Various risk factors such as, exposure to pollution, allergens, chemicals, practicing unhealthy lifestyles such as smoking are also expected to spur the market growth.
  
•   Presence of robust pipeline of agents to manage asthma is also expected to spur market growth during the forecast period.
  

Restraints:

•   However, patent expiration of drugs and high cost of asthma treatment are expected to restrain market growth during the forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The asthma therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the asthma therapeutics market in these regions.

IMPACT OF COVID-19 ON ASTHMA THERAPEUTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the asthma therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from asthma therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for asthma therapeutics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the asthma therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  Koninklijke Philips N.V

  AstraZeneca

  GlaxoSmithKline Plc.

  Teva Pharmaceutical Industries Ltd.

  Boehringer Ingelheim International GmbH

  Sanofi

  Cipla Inc

  Intas Pharmaceuticals Ltd

  Merck Sharp and Dohme Corp

  F. Hoffmann-La Roche Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Asthma Therapeutics Report Scope

Report Attribute	Details
Market size in 2023	US$ XX Million
Market Size by 2031	US$ XX Million
Global CAGR (2023 - 2031)	XX%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Type Dry powder inhalers Metered dose inhalers Mist inhalers Nebulizer By Drug Class Anti-inflammatory drugs Bronchodilators Combination therapy By Route of administration Oral Inhaled Intravenous Subcutaneous
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	AstraZeneca GlaxoSmithKline Plc. Teva Pharmaceutical Industries Ltd. Boehringer Ingelheim International GmbH Sanofi Cipla Inc Intas Pharmaceuticals Ltd Merck Sharp and Dohme Corp F. Hoffmann-La Roche Ltd